Mode
Text Size
Log in / Sign up
N/A N=189

Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Implantation

Enrolled (actual)
189
Serious AEs
Results posted
Jan 2023
Primary outcome: Primary: Post Procedure Hospital Length of Stay — 4.8; 3.5 days

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Post procedure daily PT and OT (Other); PT post procedure (Other); OT post procedure (Other); Routine PT or OT (Other)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Henry Ford Health System
Primary completion
Jul 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Post Procedure Hospital Length of Stay
4.8; 3.5
PRIMARY
Total Hospital Length of Stay
6.9; 4.5 <0.01 sig
SECONDARY
Discharge Disposition, Home
57; 99
SECONDARY
Discharge Destination, Rehab Facility
17; 16

Summary

Implementation of Physical Therapy (PT) and Occupational Therapy (OT) pathway (initiation of services on Post procedure day #1 and continued daily with focus on education and activity progression) for all patients undergoing a transcatheter aortic value repair procedure began on December 2, 2014. Retrospective data was collected from The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Aortic Valve Replacement Procedures (STS/ACC TVT, trademark) Registry - National database for Transcatherter Aortic Valve Replacement Procedures and included subjects from March 2012 through July 31, 2015. Patients included: s/p tAVR via transfemoral catheter approach, with or without minor intra or post procedure events (GI bleeds, minor access bleeds, afib, etc); Exclusions: Major events including stroke, pacemaker placement, other cardiovascular (CV) repair or surgery required, etc). Future data analysis will extend subjects to December 31, 2015 and annually.

Eligibility Criteria

Inclusion Criteria

  • admission to henry ford hospital after March 1, 2012
  • status post transcatheter aortic valve replacement via transfemoral catheter approach, with or without minor intra or post procedure events (GI bleeds, minor access bleeds, afib, etc)

Exclusion Criteria

  • Occurrence of major events including stroke, pacemaker placement, other CV repair or surgery required, etc)
  • procedure via appropriate other than femoral access (transapical, transcaval)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03117296). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search